• $170,088.00
    Market Cap
  • -67.78%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
+100.00%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
417
-91.66%
5,000
0.00%
5,000
0.00%
5,000
0.00%
Total Operating Expenses
183,005
+17.10%
156,276
-10.88%
175,364
-0.94%
177,035
-48.40%
Operating Profit
-183,005
+17.10%
-156,276
-10.88%
-175,364
-0.94%
-177,035
-48.41%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-1,627
-92.85%
-22,765
+74.61%
-13,038
-46.55%
-24,391
+34.29%
Interest Income and Expense and Net
-1,627
-92.85%
-22,765
+74.61%
-13,038
-46.55%
-24,391
+34.29%
Total Nonoperating Income and Expense
-148,607
+552.79%
-22,765
+74.61%
-13,038
-92.88%
-183,233
-29.28%
Income before Taxes
-331,612
+85.22%
-179,041
-4.97%
-188,402
-47.71%
-360,268
-40.18%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
69,749
0.00%
69,749
0.00%
69,749
0.00%
69,749
0.00%
Net Income
N/A
N/A
N/A
N/A
-188,402
-47.71%
-360,268
-40.18%
Net Income from Continuing Operations Applicable to Common
-331,612
+85.22%
-179,041
-4.97%
-188,402
-47.71%
-360,268
-40.18%
Basic EPS and Net Income
0.00
N/A
0.00
N/A
0.00
N/A
0.00
N/A
Diluted EPS and Net Income
0.00
N/A
0.00
N/A
0.00
N/A
0.00
N/A
Basic Weighted Average Shares
824,984
-99.90%
804.6M
+6.55%
755.2M
+28.48%
587.8M
+20.08%
Diluted Weighted Average Shares
824,984
-99.90%
804.6M
+6.55%
755.2M
+28.48%
587.8M
+20.08%
Balance Sheet
Cash and Cash Equivalents
815
-98.58%
57,368
-65.62%
166,859
-38.21%
270,030
-28.47%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
815
-98.58%
57,368
-65.62%
166,859
-38.21%
270,030
-28.47%
Total Current Assets
815
-98.58%
57,368
-65.62%
166,859
-38.21%
270,030
-28.47%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
815
-98.59%
57,785
-66.46%
172,276
-38.57%
280,447
-28.63%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
180,000
+4.99%
171,437
-60.26%
431,437
+65.94%
260,000
0.00%
Total Current Liabilities
263,600
+1.38%
260,000
0.00%
260,000
-5.88%
276,251
+1.67%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
22,500
0.00%
Total Long-Term Liabilities
262,429
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
742,464
-17.33%
898,058
+7.74%
833,508
+1.00%
825,277
-4.26%
Retained Earnings
-5.0M
+7.12%
-4.7M
+4.00%
-4.5M
+4.39%
-4.3M
+9.16%
Total Stockholders Equity
-741,649
N/A
N/A
N/A
-661,232
+21.36%
-544,830
+16.15%
Total Shares Outstanding
944,935
-99.88%
804.6M
0.00%
804.6M
+9.83%
732.6M
+44.04%
Cash Flow
Cash from Operating Activities
-60,153
-45.06%
-109,491
+6.13%
-103,171
-4.02%
-107,490
-54.34%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
3,600
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
-83.23%
-22.22%
-107.00%
-49.09%
Return on Equity
N/A
N/A
N/A
N/A
31.24%
-56.04%
71.07%
-55.82%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.003
-98.59%
0.22
-65.63%
0.64
-34.34%
0.98
-29.65%
Cash Ratio
0.003
-98.59%
0.22
-65.63%
0.64
-34.34%
0.98
-29.65%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
-0.52
-13.91%
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
1.01
+40.12%

Earnings & Revenue History

Debt-to-Assets

Cash Flow